Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 4Sarcoma, Myeloid 2Recurrence 2Leukemia, Monocytic, Acute 2Leukemia, Biphenotypic, Acute 2Leukemia 2Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Philadelphia Chromosome 1Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1Down Syndrome 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 49fludarabine 36Dexamethasone 35venetoclax 29pembrolizumab 26Rituximab 21Lenalidomide 18pomalidomide 17Gemcitabine 17fludarabine phosphate 15Etoposide 14Cytarabine 13daratumumab 11carfilzomib 11Temozolomide 11Cisplatin 10Calcium Dobesilate 10glofitamab 9Nivolumab 9Injections 9Azacitidine 9selinexor 8Vincristine 8Carboplatin 8Bortezomib 8obinutuzumab 7Immunotherapy, Adoptive 7Bevacizumab 7zanubrutinib 6ruxolitinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Mitoxantrone × 1 year × Clear all
NCT01279096 2026-04-22

Vandevol

University Hospital, Lille

Phase 1 Completed
20 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06660368 2026-04-01

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
52 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡